Use of Higher SPF Sunscreen Linked With Lower Melanoma Risk

Share this content:
Using sunscreen with a sun protection factor of at least 15, in contrast with sunscreens with SPF of less than 15, may reduce risk of melanoma.
Using sunscreen with a sun protection factor of at least 15, in contrast with sunscreens with SPF of less than 15, may reduce risk of melanoma.

Using sunscreen with a sun protection factor (SPF) of at least 15, in contrast with sunscreens with SPF of less than 15, may reduce risk of melanoma, according to a study published in the Journal of Clinical Oncology.1

Researchers led by Reza Ghiasvand, PhD, of the University of Oslo evaluated data of 143,844 women with 1,532,247 person-years of follow-up and 722 cases of melanoma through the prospective, population-based Norwegian Women and Cancer Study.

Multivariable Cox proportional hazards regression were used to examine the association between sunscreen use and risk for melanoma.

Observed patients who were sunscreen users had more sunburns and sunbathing vacations, and they were also more likely to use indoor tanning devices.

RELATED: Phase 2 CheckMate 069 Study Suggests Nivolumab Plus Ipilimumab May Improve Overall Survival in Melanoma

Those who used sunscreen with SPF of at least 15 had a significantly decreased risk for melanoma, compared to those who used sunscreens with an SPF of less than 15.

The estimated decrease in melanoma risk with general use of SPF of at least 15 among women aged 40 to 75 years was 18%.

Reference

  1. Ghiasvand R, Weiderpass E, Green AC, et al. Sunscreen use and subsequent melanoma risk: A population-based cohort study. J Clin Oncol. 2016 Sep 12. doi: 10.1200/JCO.2016.67.5934 [Epub ahead of print]

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters